↓ Skip to main content

Cochrane Database of Systematic Reviews

Prognostic value of test(s) for O6‐methylguanine–DNA methyltransferase (MGMT) promoter methylation for predicting overall survival in people with glioblastoma treated with temozolomide

Overview of attention for article published in Cochrane database of systematic reviews, March 2021
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (67th percentile)

Mentioned by

twitter
8 X users

Citations

dimensions_citation
25 Dimensions

Readers on

mendeley
102 Mendeley
Title
Prognostic value of test(s) for O6‐methylguanine–DNA methyltransferase (MGMT) promoter methylation for predicting overall survival in people with glioblastoma treated with temozolomide
Published in
Cochrane database of systematic reviews, March 2021
DOI 10.1002/14651858.cd013316.pub2
Pubmed ID
Authors

Alexandra McAleenan, Claire Kelly, Francesca Spiga, Ashleigh Kernohan, Hung-Yuan Cheng, Sarah Dawson, Lena Schmidt, Tomos Robinson, Sebastian Brandner, Claire L Faulkner, Christopher Wragg, Sarah Jefferies, Amy Howell, Luke Vale, Julian P T Higgins, Kathreena M Kurian

X Demographics

X Demographics

The data shown below were collected from the profiles of 8 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 102 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 102 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 17 17%
Researcher 7 7%
Student > Master 7 7%
Other 5 5%
Student > Doctoral Student 5 5%
Other 17 17%
Unknown 44 43%
Readers by discipline Count As %
Medicine and Dentistry 27 26%
Unspecified 5 5%
Nursing and Health Professions 4 4%
Biochemistry, Genetics and Molecular Biology 4 4%
Engineering 4 4%
Other 10 10%
Unknown 48 47%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 May 2022.
All research outputs
#6,872,564
of 25,388,177 outputs
Outputs from Cochrane database of systematic reviews
#8,181
of 11,906 outputs
Outputs of similar age
#137,016
of 431,348 outputs
Outputs of similar age from Cochrane database of systematic reviews
#126
of 171 outputs
Altmetric has tracked 25,388,177 research outputs across all sources so far. This one has received more attention than most of these and is in the 72nd percentile.
So far Altmetric has tracked 11,906 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 38.8. This one is in the 30th percentile – i.e., 30% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 431,348 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 67% of its contemporaries.
We're also able to compare this research output to 171 others from the same source and published within six weeks on either side of this one. This one is in the 25th percentile – i.e., 25% of its contemporaries scored the same or lower than it.